UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Camtek
CAMT
$7.13B
| $73.8M | 0.01% |
872,730
-142,577
| -14% | -$9.62M |
2024 Q2
4 quarters
|
|
602
Manulife Financial
MFC
$70.2B
| $73.5M | 0.01% |
2,300,590
+361,052
| +19% | +$11.1M |
2024 Q2
4 quarters
|
|
603
BJs Wholesale Club
BJ
$12.5B
| $73M | 0.01% |
676,894
+150,757
| +29% | +$17.2M |
2018 Q4
26 quarters
|
|
604
BioMarin Pharmaceuticals
BMRN
$10.6B
| $72.5M | 0.01% |
1,319,792
+254,868
| +24% | +$15M |
2013 Q2
48 quarters
|
|
605
DELISTED
Interpublic Group of Companies
IPG
| $71.9M | 0.01% |
2,936,538
-1,930,596
| -40% | -$46.9M |
2013 Q2
48 quarters
|
|
606
Qualys
QLYS
$7B
| $71.3M | 0.01% |
498,830
-144,408
| -22% | -$19.1M |
2013 Q2
48 quarters
|
|
607
Watsco Inc
WSO
$11.5B
| $70.8M | 0.01% |
160,389
+15,329
| +11% | +$7.11M |
2013 Q2
48 quarters
|
|
608
Simon Property Group
SPG
$64.5B
| $70.8M | 0.01% |
440,495
-3,196,142
| -88% | -$505M |
2013 Q2
48 quarters
|
|
609
Cencora
COR
$61.8B
| $70.4M | 0.01% |
234,673
-1,422,450
| -86% | -$410M |
2023 Q1
9 quarters
|
|
610
Insmed
INSM
$22B
| $70M | 0.01% |
695,961
+156,477
| +29% | +$12M |
2017 Q2
32 quarters
|
|
611
Affirm
AFRM
$27.2B
| $69.7M | 0.01% |
1,007,476
+286,746
| +40% | +$14.9M |
2021 Q2
16 quarters
|
|
612
Crown Holdings
CCK
$11.8B
| $69.5M | 0.01% |
674,686
+94,180
| +16% | +$8.97M |
2013 Q2
48 quarters
|
|
613
Canadian Imperial Bank of Commerce
CM
$99.1B
| $69.3M | 0.01% |
979,093
+49,915
| +5% | +$3.21M |
2024 Q2
4 quarters
|
|
614
Jones Lang LaSalle
JLL
$13.8B
| $68.8M | 0.01% |
269,050
+58,054
| +28% | +$13.3M |
2013 Q2
48 quarters
|
|
615
Schrodinger
SDGR
$2.04B
| $68.7M | 0.01% |
3,415,280
-942,252
| -22% | -$21.5M |
2020 Q2
20 quarters
|
|
616
Molson Coors Class B
TAP
$6.94B
| $68.1M | 0.01% |
1,415,476
+215,233
| +18% | +$11.9M |
2013 Q2
48 quarters
|
|
617
XPO
XPO
$21.5B
| $68M | 0.01% |
538,462
+235,493
| +78% | +$26.4M |
2013 Q4
46 quarters
|
|
618
Casey's General Stores
CASY
$23.9B
| $66.4M | 0.01% |
130,195
+14,521
| +13% | +$6.69M |
2013 Q2
48 quarters
|
|
619
Crown Castle
CCI
$33.9B
| $66.4M | 0.01% |
646,342
-3,861,957
| -86% | -$391M |
2013 Q2
48 quarters
|
|
620
News Corp Class A
NWSA
$15.7B
| $66.3M | 0.01% |
2,229,740
+279,019
| +14% | +$7.67M |
2013 Q3
47 quarters
|
|
621
Stanley Black & Decker
SWK
$13.4B
| $66M | 0.01% |
974,322
-131,903
| -12% | -$8.51M |
2013 Q2
48 quarters
|
|
622
Brown-Forman Class B
BF.B
$12.1B
| $66M | 0.01% |
2,451,322
+559,615
| +30% | +$18M |
2013 Q2
48 quarters
|
|
623
SoFi Technologies
SOFI
$20.4B
| $65.8M | 0.01% |
3,613,965
+888,697
| +33% | +$11.7M |
2021 Q4
14 quarters
|
|
624
East-West Bancorp
EWBC
$17.2B
| $65.7M | 0.01% |
650,921
+147,475
| +29% | +$13.1M |
2013 Q2
48 quarters
|
|
625
Zeta Global
ZETA
$8.31B
| $65.5M | 0.01% |
4,227,232
-2,079,038
| -33% | -$27.6M |
2022 Q2
12 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.